DV
Daniel Vitt
Director

Daniel Vitt insider trades: Immunic (IMUX) stock buys and sales

Director, Immunic Last trade Jun 4, 2025 17 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
6
Open-market trades
since 2020
1
Company
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Daniel reports to the SEC

Open-market buys and sales

6 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 4, 2025IMUX↑ Buy$12K
Feb 26, 2024IMUX↑ Buy$18K
Nov 22, 2022IMUX↑ Buy$11K
Jun 3, 2022IMUX↑ Buy$15K
Aug 10, 2021IMUX↑ Buy$10K
Jul 21, 2020IMUX↓ Sell10b5-1$93K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Daniel Vitt's insider trades

Daniel Vitt is a director at Immunic (IMUX). Since Jul 21, 2020, Daniel has reported 5 open-market purchases worth $66K and 1 sale worth $93K on SEC Form 4. There have been no open-market trades in the last 12 months.

1 sale (100% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.

Their filings also include grants and awards (12 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IMUX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.